BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22101133)

  • 41. Discovery of triazolone derivatives as novel, potent stearoyl-CoA desaturase-1 (SCD1) inhibitors.
    Sun S; Zhang Z; Pokrovskaia N; Chowdhury S; Jia Q; Chang E; Khakh K; Kwan R; McLaren DG; Radomski CC; Ratkay LG; Fu J; Dales NA; Winther MD
    Bioorg Med Chem; 2015 Feb; 23(3):455-65. PubMed ID: 25555732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogs.
    Yang SM; Tang Y; Rano T; Lu H; Kuo GH; Gaul MD; Li Y; Ho G; Lang W; Conway JG; Liang Y; Lenhard JM; Demarest KT; Murray WV
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1437-41. PubMed ID: 24405703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel assay of cellular stearoyl-CoA desaturase activity of primary rat hepatocytes by HPLC.
    Su C; Gullberg H; Simko H; Luthman M; Edlund PO; Lundbäck T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(26):2427-32. PubMed ID: 20732836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenoxy thiazole derivatives as potent and selective acetyl-CoA carboxylase 2 inhibitors: Modulation of isozyme selectivity by incorporation of phenyl ring substituents.
    Clark RF; Zhang T; Wang X; Wang R; Zhang X; Camp HS; Beutel BA; Sham HL; Gu YG
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1961-5. PubMed ID: 17267221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors.
    Kopecky DJ; Hao X; Chen Y; Fu J; Jiao X; Jaen JC; Cardozo MG; Liu J; Wang Z; Walker NP; Wesche H; Li S; Farrelly E; Xiao SH; Kayser F
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6352-6. PubMed ID: 18993068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of Cytochrome P450 4F11 Activated Inhibitors of Stearoyl Coenzyme A Desaturase.
    Winterton SE; Capota E; Wang X; Chen H; Mallipeddi PL; Williams NS; Posner BA; Nijhawan D; Ready JM
    J Med Chem; 2018 Jun; 61(12):5199-5221. PubMed ID: 29869888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel benzoylpiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 6-[4-(2-methylbenzoyl)piperidin-1-yl]pyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl)amide and its plasma triglyceride-lowering effects in Zucker fatty rats.
    Uto Y; Ogata T; Kiyotsuka Y; Ueno Y; Miyazawa Y; Kurata H; Deguchi T; Watanabe N; Konishi M; Okuyama R; Kurikawa N; Takagi T; Wakimoto S; Ohsumi J
    Bioorg Med Chem Lett; 2010 Jan; 20(1):341-5. PubMed ID: 19926281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Azacycloalkane derivatives as inhibitors of delta-9 stearoyl-coenzyme A desaturase.
    Liu G
    Expert Opin Ther Pat; 2009 Jun; 19(6):885-91. PubMed ID: 19473107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-benzylimidazole carboxamides as potent, orally active stearoylCoA desaturase-1 inhibitors.
    Atkinson KA; Beretta EE; Brown JA; Castrodad M; Chen Y; Cosgrove JM; Du P; Litchfield J; Makowski M; Martin K; McLellan TJ; Neagu C; Perry DA; Piotrowski DW; Steppan CM; Trilles R
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1621-5. PubMed ID: 21324691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of stearoyl-CoA desaturase activity by the trans-10,cis-12 isomer of conjugated linoleic acid in HepG2 cells.
    Choi Y; Park Y; Pariza MW; Ntambi JM
    Biochem Biophys Res Commun; 2001 Jun; 284(3):689-93. PubMed ID: 11396956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of hepatic desaturases in obesity-related metabolic disorders.
    Bjermo H; Risérus U
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):703-8. PubMed ID: 20823776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beta-C-glycosiduronic acids and beta-C-glycosyl compounds: new PTP1B inhibitors.
    Lin L; Shen Q; Chen GR; Xie J
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6348-51. PubMed ID: 18993066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors.
    Ahn JH; Shin MS; Jun MA; Jung SH; Kang SK; Kim KR; Rhee SD; Kang NS; Kim SY; Sohn SK; Kim SG; Jin MS; Lee JO; Cheon HG; Kim SS
    Bioorg Med Chem Lett; 2007 May; 17(9):2622-8. PubMed ID: 17331715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimization.
    Matter H; Zoller G; Herling AW; Sanchez-Arias JA; Philippo C; Namane C; Kohlmann M; Pfenninger A; Voss MD
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1817-22. PubMed ID: 23395660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
    Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of thiophene inhibitors of polo-like kinase.
    Emmitte KA; Andrews CW; Badiang JG; Davis-Ward RG; Dickson HD; Drewry DH; Emerson HK; Epperly AH; Hassler DF; Knick VB; Kuntz KW; Lansing TJ; Linn JA; Mook RA; Nailor KE; Salovich JM; Spehar GM; Cheung M
    Bioorg Med Chem Lett; 2009 Feb; 19(3):1018-21. PubMed ID: 19097784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stearoylethanolamide exerts anorexic effects in mice via down-regulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression.
    Terrazzino S; Berto F; Dalle Carbonare M; Fabris M; Guiotto A; Bernardini D; Leon A
    FASEB J; 2004 Oct; 18(13):1580-2. PubMed ID: 15289450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological inhibition of stearoyl-CoA desaturase 1 improves insulin sensitivity in insulin-resistant rat models.
    Issandou M; Bouillot A; Brusq JM; Forest MC; Grillot D; Guillard R; Martin S; Michiels C; Sulpice T; Daugan A
    Eur J Pharmacol; 2009 Sep; 618(1-3):28-36. PubMed ID: 19616540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma-based approach to measure target engagement for liver-targeting stearoyl-CoA desaturase 1 inhibitors.
    Landry F; Chan CC; Huang Z; Leclair G; Li CS; Oballa R; Zhang L; Bateman K
    J Lipid Res; 2011 Aug; 52(8):1494-9. PubMed ID: 21642745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conjugated linoleic acid decreases hepatic stearoyl-CoA desaturase mRNA expression.
    Lee KN; Pariza MW; Ntambi JM
    Biochem Biophys Res Commun; 1998 Jul; 248(3):817-21. PubMed ID: 9704011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.